/
Stock
/
/
APIChangelogInfo
Common stock only
S&P 500 only
Director Only
10% Owner Only

Trans Codes

Select...
Amount
-

TAYSHA GENE THERAPIES

Trade TSHA
TSHA Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25-8081624324004M8M12M16M20M24M






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-06-02
2025-06-04
DONENBERG PHILLIP
A - Grant
Stock Option (right to buy)
113K
$0.00
1
$560.27M
2025-06-02
2025-06-04
LONG ALISON
A - Grant
Stock Option (right to buy)
113K
$0.00
1
$560.27M
2025-06-02
2025-06-04
LONG ALISON
A - Grant
Common Stock
56,623
$0.00
1
$560.27M
2025-06-02
2025-06-04
DONENBERG PHILLIP
A - Grant
Common Stock
56,623
$0.00
1
$560.27M
2025-06-02
2025-06-04
SEPP-LORENZINO LAURA
A - Grant
Stock Option (right to buy)
113K
$0.00
1
$560.27M
2025-06-02
2025-06-04
SEPP-LORENZINO LAURA
A - Grant
Common Stock
56,623
$0.00
1
$560.27M
2025-06-02
2025-06-04
STALFORT JOHN III
A - Grant
Stock Option (right to buy)
113K
$0.00
1
$560.27M
2025-06-02
2025-06-04
STALFORT JOHN III
A - Grant
Common Stock
56,623
$0.00
1
$560.27M
2025-05-30
2025-06-03
MANNING PAUL
P - Purchase
Common Stock
750K
$3.00
2.25M
1
$560.27M
2023-05-31
2025-04-10
ALAM KAMRAN
CHIEF FINANCIAL OFFICER
A - Grant
Employee Stock Option (right to buy)
12,462
$0.00
1
$560.27M
2025-03-11
2025-03-13
ALAM KAMRAN
CHIEF FINANCIAL OFFICER
F - Tax
Common Stock
-29,843
$2.00
-59,686
1
$560.27M
2025-01-02
2025-01-03
NOLAN SEAN
Chief Executive Officer
A - Grant
Common Stock
893K
$0.00
1
$560.27M
2025-01-02
2025-01-03
ALAM KAMRAN
CHIEF FINANCIAL OFFICER
A - Grant
Employee Stock Option (right to buy)
431K
$0.00
1
$560.27M
2025-01-02
2025-01-03
ALAM KAMRAN
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
431K
$0.00
1
$560.27M
2025-01-02
2025-01-03
NAGENDRAN SUKUMAR
President and Head of R&D
A - Grant
Employee Stock Option (right to buy)
325K
$0.00
1
$560.27M
2025-01-02
2025-01-03
NAGENDRAN SUKUMAR
President and Head of R&D
A - Grant
Common Stock
325K
$0.00
1
$560.27M
2025-01-02
2025-01-03
NOLAN SEAN
Chief Executive Officer
A - Grant
Employee Stock Option (right to buy)
893K
$0.00
1
$560.27M
2024-07-05
2024-07-05
MCAULIFFE SEAN
S - Sale
-25,505
$2.00
-51,010
1
$560.27M
2024-07-05
2024-07-05
MCGINNIS EMILY
S - Sale
-16,869
$2.00
-33,738
1
$560.27M
2024-07-05
2024-07-05
PORTER FRED
S - Sale
-33,335
$2.00
-66,670
1
$560.27M
2024-06-27
2024-07-01
MANNING PAUL
P - Purchase
Common Stock
1.33M
$2.00
2.67M
1
$560.27M
2024-05-29
2024-05-31
DONENBERG PHILLIP
A - Grant
Stock Option (right to buy)
98,440
$0.00
1
$560.27M
2024-05-29
2024-05-31
DONENBERG PHILLIP
A - Grant
Common Stock
49,220
$0.00
1
$560.27M
2024-05-29
2024-05-31
LONG ALISON
A - Grant
Stock Option (right to buy)
98,440
$0.00
1
$560.27M
2024-05-29
2024-05-31
LONG ALISON
A - Grant
Common Stock
49,220
$0.00
1
$560.27M
2024-05-29
2024-05-31
SEPP-LORENZINO LAURA
A - Grant
Stock Option (right to buy)
98,440
$0.00
1
$560.27M
2024-05-29
2024-05-31
SEPP-LORENZINO LAURA
A - Grant
Common Stock
49,220
$0.00
1
$560.27M
2024-05-29
2024-05-31
STALFORT JOHN III
A - Grant
Stock Option (right to buy)
98,440
$0.00
1
$560.27M
2024-05-29
2024-05-31
STALFORT JOHN III
A - Grant
Common Stock
49,220
$0.00
1
$560.27M
2024-02-02
2024-02-06
ALAM KAMRAN
CHIEF FINANCIAL OFFICER
F - Tax
Common Stock
-1,288
$2.00
-2,576
1
$560.27M
2024-01-02
2024-01-04
NAGENDRAN SUKUMAR
President and Head of R&D
A - Grant
Common Stock
864K
$0.00
1
$560.27M
2024-01-02
2024-01-04
ALAM KAMRAN
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
590K
$0.00
1
$560.27M
2024-01-02
2024-01-04
ALAM KAMRAN
Chief Financial Officer
A - Grant
Common Stock
590K
$0.00
1
$560.27M
2024-01-02
2024-01-04
NAGENDRAN SUKUMAR
President and Head of R&D
A - Grant
Employee Stock Option (right to buy)
864K
$0.00
1
$560.27M
2024-01-02
2024-01-04
NOLAN SEAN
Chief Executive Officer
A - Grant
Employee Stock Option (right to buy)
1.18M
$0.00
1
$560.27M
2024-01-02
2024-01-04
NOLAN SEAN
Chief Executive Officer
A - Grant
Common Stock
1.18M
$0.00
1
$560.27M
2023-12-14
2023-12-18
NOLAN SEAN
Chief Executive Officer
A - Grant
Employee Stock Option (right to buy)
467K
$0.00
1
$560.27M
2023-12-14
2023-12-18
ALAM KAMRAN
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
188K
$0.00
1
$560.27M
2023-12-14
2023-12-18
NAGENDRAN SUKUMAR
President and Head of R&D
A - Grant
Employee Stock Option (right to buy)
334K
$0.00
1
$560.27M
2023-11-17
2023-11-20
MANNING PAUL
P - Purchase
Common Stock
100K
$2.00
200K
1
$560.27M
2023-11-01
2023-11-03
LONG ALISON
A - Grant
Stock Option (right to buy)
43,800
$0.00
1
$560.27M
2023-08-24
2023-08-25
ALAM KAMRAN
Chief Financial Officer
S - Sale
Common Stock
-33,000
$2.00
-66,000
1
$560.27M
2023-08-16
2023-08-16
STALFORT JOHN III
G - Gift
Common Stock
50,000
$0.00
1
$560.27M
2023-08-16
2023-08-16
DONENBERG PHILLIP
P - Purchase
Common Stock
111K
$1.00
111K
1
$560.27M
2023-08-16
2023-08-16
MANNING PAUL
P - Purchase
Common Stock
16M
$1.00
16M
1
$560.27M
2023-08-16
2023-08-16
STALFORT JOHN III
P - Purchase
Common Stock
778K
$1.00
778K
2
$560.27M
2023-08-16
2023-08-16
NOLAN SEAN
Chief Executive Officer
P - Purchase
Common Stock
444K
$1.00
444K
1
$560.27M
2023-07-13
2023-07-14
SESSION R.A. II
S - Sale
Common Stock
-5,344
$1.00
-5,344
1
$560.27M
2023-07-12
2023-07-14
SESSION R.A. II
S - Sale
Common Stock
-80,528
$1.00
-80,528
1
$560.27M
2023-06-23
2023-06-26
SESSION R.A. II
S - Sale
Common Stock
-18,100
$1.00
-18,100
1
$560.27M
2023-06-22
2023-06-26
SEPP-LORENZINO LAURA
A - Grant
Stock Option (right to buy)
36,200
$0.00
1
$560.27M
2023-06-22
2023-06-26
DONENBERG PHILLIP
A - Grant
Stock Option (right to buy)
36,200
$0.00
1
$560.27M
2023-06-22
2023-06-26
REAPE KATHLEEN
A - Grant
Stock Option (right to buy)
36,200
$0.00
1
$560.27M
2023-06-22
2023-06-26
STALFORT JOHN III
A - Grant
Stock Option (right to buy)
43,800
$0.00
1
$560.27M
2023-06-22
2023-06-26
SESSION R.A. II
S - Sale
Common Stock
-10,508
$1.00
-10,508
1
$560.27M
2023-06-21
2023-06-22
SESSION R.A. II
S - Sale
Common Stock
-139K
$1.00
-139K
1
$560.27M
2023-06-20
2023-06-22
SESSION R.A. II
S - Sale
Common Stock
-296K
$1.00
-296K
1
$560.27M
2023-06-20
2023-06-20
SESSION II
S - Sale
-1.01M
$1.00
-1.01M
1
$560.27M
2023-06-20
2023-06-20
R.A. SESSIONS II
S - Sale
-1.01M
$1.00
-1.01M
1
$560.27M
2023-05-31
2023-06-02
ALAM KAMRAN
Chief Financial Officer
A - Grant
Common Stock
6,230
1
$560.27M
2023-06-05
2023-06-01
MCAULIFFE SEAN
S - Sale
-21,305
$1.00
-21,305
1
$560.27M
2023-06-05
2023-06-01
PORTER FRED
S - Sale
-42,491
$1.00
-42,491
1
$560.27M
2023-05-16
2023-05-18
NAGENDRAN SUKUMAR
President and Head of R&D
P - Purchase
Common Stock
5,000
$1.00
5,000
1
$560.27M
2023-05-11
2023-05-11
MCGINNIS EMILY
S - Sale
-19,784
$2.00
-39,568
1
$560.27M
2023-03-06
2023-03-08
SESSION R.A. II
D - Sale to Issuer
Employee Stock Option (right to buy)
-200K
1
$560.27M
2023-03-06
2023-03-08
SESSION R.A. II
J - Other
Common Stock
251K
$0.00
1
$560.27M
2023-02-02
2023-02-06
ALAM KAMRAN
Chief Financial Officer
A - Grant
Common Stock
18,691
1
$560.27M
2023-02-02
2023-02-06
ALAM KAMRAN
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
187K
$0.00
2
$560.27M
2022-12-30
2023-01-04
NOLAN SEAN
Chief Executive Officer
A - Grant
Stock Option (right to buy)
1.11M
$0.00
1
$560.27M
2022-12-30
2023-01-04
NAGENDRAN SUKUMAR
President and Head of R&D
A - Grant
Stock Option (right to buy)
790K
$0.00
1
$560.27M
2022-11-10
2022-12-23
SESSION R.A. II
A - Grant
Employee Stock Option (right to buy)
200K
$0.00
1
$560.27M
2022-10-31
2022-11-02
MANNING PAUL
P - Purchase
Common Stock
1.50M
$2.00
3.00M
1
$560.27M
2022-08-23
2022-08-24
ALAM KAMRAN
Chief Financial Officer
S - Sale
Common Stock
-3,325
$3.00
-9,975
1
$560.27M
2022-08-22
2022-08-22
ALAM KAMRAN
Chief Financial Officer
S - Sale
Common Stock
-9,717
$4.00
-38,868
1
$560.27M
2022-08-19
2022-08-22
ALAM KAMRAN
Chief Financial Officer
S - Sale
Common Stock
-11,482
$4.00
-45,928
1
$560.27M
2022-08-18
2022-08-22
ALAM KAMRAN
Chief Financial Officer
S - Sale
Common Stock
-7,476
$4.00
-29,904
1
$560.27M
2022-07-06
2022-07-07
PRASAD SUYASH
CMO and Head of R&D
S - Sale
Common Stock
-8,956
$4.00
-35,824
1
$560.27M
2022-07-05
2022-07-07
PRASAD SUYASH
CMO and Head of R&D
S - Sale
Common Stock
-3,905
$4.00
-15,620
1
$560.27M
2022-07-01
2022-07-01
PRASAD SUYASH
CMO and Head of R&D
S - Sale
Common Stock
-23,923
$4.00
-95,692
1
$560.27M
2022-06-30
2022-07-01
PRASAD SUYASH
CMO and Head of R&D
S - Sale
Common Stock
-13,892
$4.00
-55,568
1
$560.27M
2022-06-29
2022-07-01
PRASAD SUYASH
CMO and Head of R&D
S - Sale
Common Stock
-12,324
$4.00
-49,296
1
$560.27M
2022-06-17
2022-06-22
NAGENDRAN SUKUMAR
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2022-06-17
2022-06-22
DONENBERG PHILLIP
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2022-06-17
2022-06-22
MANNING PAUL
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2022-06-17
2022-06-22
NOLAN SEAN
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2022-06-17
2022-06-22
REAPE KATHLEEN
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2022-06-17
2022-06-22
SEPP-LORENZINO LAURA
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2022-04-06
2022-04-08
ALAM KAMRAN
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
40,000
$0.00
1
$560.27M
2022-04-06
2022-04-08
PRASAD SUYASH
CMO and Head of R&D
A - Grant
Employee Stock Option (right to buy)
40,325
$0.00
1
$560.27M
2022-02-23
2022-02-25
ALAM KAMRAN
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
80,000
$0.00
1
$560.27M
2022-02-23
2022-02-25
PRASAD SUYASH
CMO and Head of R&D
A - Grant
Employee Stock Option (right to buy)
80,650
$0.00
1
$560.27M
2022-02-23
2022-02-25
SESSION R.A. II
President and CEO
A - Grant
Employee Stock Option (right to buy)
218K
$0.00
1
$560.27M
2022-02-03
2022-02-04
MANNING PAUL
P - Purchase
Common Stock
76,602
$8.00
613K
2
$560.27M
2022-02-02
2022-02-04
MANNING PAUL
P - Purchase
Common Stock
125K
$8.00
1.00M
3
$560.27M
2022-02-02
2022-02-03
DONENBERG PHILLIP
P - Purchase
Common Stock
3,000
$8.00
24,000
1
$560.27M
2022-02-02
2022-02-03
NAGENDRAN SUKUMAR
P - Purchase
Common Stock
10,000
$8.00
80,000
1
$560.27M
2021-11-23
2021-12-08
SESSION R.A. II
President and CEO
P - Purchase
Common Stock
42,518
$12.00
510K
2
$560.27M
2021-11-24
2021-11-29
MANNING PAUL
P - Purchase
Common Stock
2,202
$13.00
28,626
1
$560.27M
2021-11-23
2021-11-24
MANNING PAUL
P - Purchase
Common Stock
20,000
$13.00
260K
1
$560.27M
2021-08-20
2021-08-20
ALAM KAMRAN
Chief Financial Officer
S - Sale
Common Stock
-11,840
$17.00
-201K
2
$560.27M
2021-08-19
2021-08-20
ALAM KAMRAN
Chief Financial Officer
S - Sale
Common Stock
-9,967
$16.00
-159K
2
$560.27M
2021-08-18
2021-08-20
ALAM KAMRAN
Chief Financial Officer
S - Sale
Common Stock
-11,193
$17.00
-190K
1
$560.27M
2021-07-01
2021-07-01
PRASAD SUYASH
CMO and Head of R&D
S - Sale
Common Stock
-19,706
$21.00
-414K
1
$560.27M
2021-06-30
2021-07-01
PRASAD SUYASH
CMO and Head of R&D
S - Sale
Common Stock
-20,076
$22.00
-442K
3
$560.27M
2021-06-29
2021-07-01
PRASAD SUYASH
CMO and Head of R&D
S - Sale
Common Stock
-39,218
$24.00
-941K
3
$560.27M
2021-06-17
2021-06-21
SEPP-LORENZINO LAURA
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2021-06-17
2021-06-21
NOLAN SEAN
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2021-06-17
2021-06-21
DONENBERG PHILLIP
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2021-06-17
2021-06-21
MANNING PAUL
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2021-06-17
2021-06-21
NAGENDRAN SUKUMAR
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2021-06-17
2021-06-21
REAPE KATHLEEN
A - Grant
Stock Option (right to buy)
15,500
$0.00
1
$560.27M
2021-05-20
2021-05-24
NOLAN SEAN
P - Purchase
Common Stock
1,170
$22.00
25,740
1
$560.27M
2021-05-14
2021-05-17
MANNING PAUL
P - Purchase
Common Stock
12,000
$21.00
252K
1
$560.27M
2020-12-31
2021-02-16
MANNING PAUL
G - Gift
Common Stock
-80,000
$0.00
1
$560.27M
2021-01-19
2021-01-20
ALAM KAMRAN
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
70,000
$0.00
1
$560.27M
2021-01-19
2021-01-20
PRASAD SUYASH
CMO and Head of R&D
A - Grant
Stock Option (Right to Buy)
80,000
$0.00
1
$560.27M
2021-01-19
2021-01-20
SESSION R.A. II
President and CEO
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$560.27M
2020-11-23
2020-11-24
REAPE KATHLEEN
A - Grant
Stock Option (right to buy)
31,000
$0.00
1
$560.27M
2020-11-23
2020-11-24
SEPP-LORENZINO LAURA
A - Grant
Stock Option (right to buy)
31,000
$0.00
1
$560.27M
2020-09-28
2020-09-30
MANNING PAUL
C - Conversion
Series A Preferred Stock
-4.85M
$0.00
2
$560.27M
2020-09-28
2020-09-30
MANNING PAUL
C - Conversion
Series B Preferred Stock
-10,963
$0.00
1
$560.27M
2020-09-28
2020-09-30
MANNING PAUL
C - Conversion
Common Stock
5.30M
3
$560.27M
2020-09-28
2020-09-30
NAGENDRAN SUKUMAR
C - Conversion
Series B Preferred Stock
-17,647
$0.00
1
$560.27M
2020-09-28
2020-09-30
NAGENDRAN SUKUMAR
C - Conversion
Common Stock
19,226
1
$560.27M
2020-09-28
2020-09-30
NOLAN SEAN
C - Conversion
Series A Preferred Stock
-1.00M
$0.00
1
$560.27M
2020-09-28
2020-09-30
NOLAN SEAN
C - Conversion
Series B Preferred Stock
-1,470
$0.00
1
$560.27M
2020-09-28
2020-09-30
NOLAN SEAN
C - Conversion
Common Stock
1.09M
2
$560.27M
2020-09-28
2020-09-30
PRASAD SUYASH
CMO and Head of R&D
C - Conversion
Series B Preferred Stock
-3,529
$0.00
1
$560.27M
2020-09-28
2020-09-30
PRASAD SUYASH
CMO and Head of R&D
C - Conversion
Common Stock
3,844
1
$560.27M
2020-09-23
2020-09-25
ALAM KAMRAN
Chief Financial Officer
A - Grant
Common Stock
331K
1
$560.27M
2020-09-23
2020-09-25
DONENBERG PHILLIP
A - Grant
Stock Option (right to buy)
31,000
$0.00
1
$560.27M
2020-09-23
2020-09-25
MANNING PAUL
A - Grant
Stock Option (right to buy)
31,000
$0.00
1
$560.27M
2020-09-23
2020-09-25
NAGENDRAN SUKUMAR
A - Grant
Stock Option (right to buy)
31,000
$0.00
1
$560.27M
2020-09-23
2020-09-25
NOLAN SEAN
A - Grant
Stock Option (right to buy)
31,000
$0.00
1
$560.27M
2020-09-23
2020-09-25
PRASAD SUYASH
CMO and Head of R&D
A - Grant
Common Stock
669K
1
$560.27M